Biotech · Private company
Bridge Biotherapeutics, Inc.
Track this companyFree. Adds Bridge Biotherapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials70 recruiting or active
Pipeline programs10From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline10
- BBT-877Phase 2 · Idiopathic Pulmonary FibrosisClinicalTrials.gov · fetched Nov 12, 2026
- BBT-401-1S, Multiple dosesPhase 1 · Ulcerative ColitisClinicalTrials.gov · fetched Nov 12, 2026
- BBT-401-1S, Single dosePhase 1 · Ulcerative ColitisClinicalTrials.gov · fetched Nov 12, 2026
- BBT-877Phase 1 · Healthy ParticipantsClinicalTrials.gov · fetched Nov 12, 2026
- BBT-877 single dosePhase 1 · Healthy ParticipantsClinicalTrials.gov · fetched Nov 12, 2026
- BBT-877, Multiple dosesPhase 1 · Idiopathic Pulmonary FibrosisClinicalTrials.gov · fetched Nov 12, 2026
- BBT-877, Single dosePhase 1 · Idiopathic Pulmonary FibrosisClinicalTrials.gov · fetched Nov 12, 2026
- EsomeprazolePhase 1 · Healthy ParticipantsClinicalTrials.gov · fetched Nov 12, 2026
- ItraconazolePhase 1 · Healthy ParticipantsClinicalTrials.gov · fetched Nov 12, 2026
- MidazolamPhase 1 · Healthy ParticipantsClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials7
- To Evaluate the Efficacy, Safety, and Tolerability of BBT-877 in Patients With IPFPHASE2 · COMPLETED · started Apr 12, 2023ClinicalTrials.gov NCT05483907 · fetched Nov 12, 2026
- Efficacy and Safety of Orally Administered BBT-401-1S in Subjects With Ulcerative ColitisPHASE2 · COMPLETED · started Jun 11, 2021ClinicalTrials.gov NCT04596293 · fetched Nov 12, 2026
- Evaluate Safety, Pharmacokinetics and Pharmacodynamics of BBT-877 in Healthy Japanese MalePHASE1 · COMPLETED · started Oct 1, 2019ClinicalTrials.gov NCT04138849 · fetched Nov 12, 2026
- Assess the Drug Interactions of BBT-877 and Midazolam, Itraconazole, and Esomeprazole in Healthy Adult SubjectsPHASE1 · COMPLETED · started Sep 17, 2019ClinicalTrials.gov NCT04138836 · fetched Nov 12, 2026
- Efficacy and Safety of BBT-401-1S in Ulcerative ColitisPHASE2 · TERMINATED · started Apr 22, 2019ClinicalTrials.gov NCT03800420 · fetched Nov 12, 2026
- Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BBT-877 in Healthy SubjectsPHASE1 · COMPLETED · started Feb 13, 2019ClinicalTrials.gov NCT03830125 · fetched Nov 12, 2026
- First-In-Human Study of BBT-401-1S Following Single and Multiple Ascending Doses in Healthy VolunteersPHASE1 · COMPLETED · started Mar 20, 2018ClinicalTrials.gov NCT03482648 · fetched Nov 12, 2026